APA (7th ed.) Citation

Pereira da Costa, R., Lima, M., Guedes, S., Vieira, M., Costa Reis, P., Claro, A., . . . Oliveira-Ramos, F. (2026). Emapalumab’s role in a severe and treatment-resistant paediatric macrophage activation syndrome. ARP Rheumatology, 5(1), 71. https://doi.org/10.63032/BPDO4893

Chicago Style (17th ed.) Citation

Pereira da Costa, R., et al. "Emapalumab’s Role in a Severe and Treatment-resistant Paediatric Macrophage Activation Syndrome." ARP Rheumatology 5, no. 1 (2026): 71. https://doi.org/10.63032/BPDO4893.

MLA (9th ed.) Citation

Pereira da Costa, R., et al. "Emapalumab’s Role in a Severe and Treatment-resistant Paediatric Macrophage Activation Syndrome." ARP Rheumatology, vol. 5, no. 1, 2026, p. 71, https://doi.org/10.63032/BPDO4893.